Skip to NavigationSkip to content

News

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and hepatitis.
The EMA has judged that the benefits offered by Zinbryta do not outweigh its risks, following a review carried out by the agency’s Pharmacovigilance...
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements...
The FDA has revealed its decision to approve AstraZeneca’s oral potassium-removing agent Lokelma (sodium zirconium cyclosilicate) for the treatment...
Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians.
Novartis lands itself in hot water over questionable deal with Trump's lawyer, while UK MPs demand UK pharma be aligned with EU operations post-...
The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was a case of a person...
Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial onset seizures...
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig is the first CGRP inhibitor to...
A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just as effective after a...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches